FVR C-P Vaccine

This page contains information on FVR C-P Vaccine for veterinary use.
The information provided typically includes the following:
  • FVR C-P Vaccine Indications
  • Warnings and cautions for FVR C-P Vaccine
  • Direction and dosage information for FVR C-P Vaccine

Fvr C-p Vaccine

This treatment applies to the following species:
Manufacturer: Intervet/Schering-Plough Animal Health

Feline Rhinotracheitis-calici-panleukopenia Vaccine

Modified Live And Killed Virus

For veterinary use in cats only

Product Description

FVR® C-P vaccine is a combination of antigens for convenient use in healthy cats 8 to 9 weeks of age or older as an aid in the prevention of disease caused by feline rhinotracheitis, feline calici and feline panleukopenia viruses. The feline rhinotracheitis-calici component is a lyophilized suspension of modified live viruses propagated in a stable cell line of feline origin and backfilled with an inert gas. The feline panleukopenia virus is propagated in a stable cell line of feline origin. The virus has been chemically inactivated and determined to be non-viricidal when used as a diluent to rehydrate the feline rhinotracheitis-calici vaccine. The safety and efficacy of each virus strain has been demonstrated by vaccination and challenge tests in healthy susceptible cats.

FVR C-P Vaccine Dosage And Administration

Transfer contents of the PANAGEN® vaccine vial to the FVR® C vial aseptically. Mix gently until dissolved. Use entire contents immediately after rehydration.

Prior To Use, Warm The Panagen® Vaccine To Room Temperature And Shake Well.

Two doses are required for primary immunization.

Initial vaccination: Inject 1 dose (1 mL) subcutaneously or intramuscularly at 8 to 9 weeks of age or older.

Second vaccination: Inject 1 dose (1 mL) subcutaneously or intramuscularly 3 to 4 weeks following the initial vaccination.

If the animal is less than 12 weeks of age, it should be revaccinated every 3 to 4 weeks until 12 to 16 weeks of age.

Annual revaccination with one dose is recommended.

Precautions

Store at 2°-7°C.

Do not freeze.

Do not mix with other vaccines.

Use new, non-chemically sterilized needles and syringes.

Burn vaccine container and all unused contents.

Warnings

Contains gentamicin and amphotericin B as preservatives.

Some reports suggest that in cats, the administration of certain veterinary biologicals may induce the development of injection-site fibrosarcomas.

Do not vaccinate pregnant cats.

The use of a biological product may produce anaphylaxis and/or other inflammatory immune-mediated hypersensitivity reactions.

Antidote

Epinephrine, corticosteroids, and antihistamines may all be indicated depending on the nature and severity of the reaction.

U.S. Veterinary License No. 165A

Schering-Plough Animal Health Corporation, Omaha, Nebraska 68103 USA

1 800 224-5318 (USA)

1 888 306-0069 (Canada)

© Copyright 1999, 2001, 2006, Schering-Plough Animal Health Corp.

All rights reserved.

 

NDC

 

25x1 DOSE

0061-5135-01

P18702-13

Nac No.

10470782

INTERVET/SCHERING-PLOUGH ANIMAL HEALTH
Distributed by INTERVET/SCHERING-PLOUGH ANIMAL HEALTH
29160 INTERVET LANE, P.O. BOX 318, MILLSBORO, DE, 19966-0318
Toll-Free:   800-992-8051
Customer Service:   800-441-8272
Website:   www.intervetusa.com
Email:   Information.USA@intervet.com
Every effort has been made to ensure the accuracy of the FVR C-P Vaccine information published above. However, it remains the responsibility of the readers to familiarize themselves with the product information contained on the US product label or package insert.

Copyright © 2014 North American Compendiums. Updated: 2014-04-11

(web5)